glp 1 agonist black box warning New Injectable - "TwinCretin" on Printed PocketCards The Dark Side of Ozempic
Description
Sequencing of 640,000 exomes identifies
[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Yuma T., Tokuda M., Nishimoto N., Yokoi H., Izumori K
Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications
[Google Scholar] 15.Fodden J.H., Read W.O
doi: 10.1210/jcem.76.4.8473405
Novel foods authorisation guidance
